Furthermore, Davidson et al. assessed the expressions of E-cadherin, vimentin, and SOX11 in 100 advanced-stage serous ovarian carcinoma pleural effusions using immunohistochemistry and reported that only vimentin expression was significantly related to poor chemotherapy response at diagnosis [35]. This evidence concerns the gene VIM and ovarian serous carcinoma.